Willard H. Dere - Apr 10, 2025 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Stock symbol
MCRB
Transactions as of
Apr 10, 2025
Transactions value $
$0
Form type
4
Date filed
4/11/2025, 04:05 PM
Previous filing
Jun 12, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +100K $0.00 100K Apr 10, 2025 Common Stock 100K $0.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders.